Save your place

Sign in to WhoBought

Please try again later.

Ray Dalio's Novo Nordisk A/S (NVO) position

Not anymore: Ray Dalio fully exited NVO in Q4 2025. The position peaked at $7.7M in Q3 2025.
View full portfolio →
Value at exit
$7.7M
Shares at exit
139K
Est. average buy price (i)
$58.55
Quarter-end price
$55.49

Estimated trade prices

Average price in quarters with purchases
$58.55

NVO price vs Dalio's position

Dates
$30$100$15020222023202420252026New position of 139K shares · Q3 2025. Average closing price $58.55 · Price range $45.38–$71.70139Ksharespurchased
Average closing price · filing quarter
$58.55
Price range · filing quarter
$45.38 – $71.70

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q4 2025 Exited −139K −$7.1M −100.0% 0 Feb 13, 2026
Q3 2025 New +139K +$8.1M 139K Nov 13, 2025
Data through Q4 2025 · filed Feb 13, 2026
2 grouped rows from 2 quarters

More Dalio positions

Common questions

Does Ray Dalio own NVO?

Not currently. Ray Dalio fully exited NVO in Q4 2025, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ray Dalio buy NVO?

Ray Dalio first disclosed a NVO position in Q3 2025; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ray Dalio sell NVO?

Yes. Ray Dalio reduced and then fully exited NVO by Q4 2025; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of NVO does Ray Dalio own?

None as of the latest filing: Ray Dalio has exited NVO. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ray Dalio pay for NVO?

Ray Dalio's estimated average buy price for NVO is $58.55, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.